NCT04324125View on ClinicalTrials.gov

Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC

RecruitingOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

March 24, 2020

Primary Completion Date

December 24, 2024

Study Completion Date

March 24, 2025

Conditions

Non Small Cell Lung Cancer

Trial Locations (1)

410013

RECRUITING

Yongchang Zhang, Changsha

All Listed Sponsors

lead

Hunan Province Tumor Hospital

OTHER